Correlation Between Eventide Healthcare and Gmo Emerging
Can any of the company-specific risk be diversified away by investing in both Eventide Healthcare and Gmo Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eventide Healthcare and Gmo Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eventide Healthcare Life and Gmo Emerging Country, you can compare the effects of market volatilities on Eventide Healthcare and Gmo Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eventide Healthcare with a short position of Gmo Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eventide Healthcare and Gmo Emerging.
Diversification Opportunities for Eventide Healthcare and Gmo Emerging
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eventide and Gmo is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Eventide Healthcare Life and Gmo Emerging Country in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gmo Emerging Country and Eventide Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eventide Healthcare Life are associated (or correlated) with Gmo Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gmo Emerging Country has no effect on the direction of Eventide Healthcare i.e., Eventide Healthcare and Gmo Emerging go up and down completely randomly.
Pair Corralation between Eventide Healthcare and Gmo Emerging
Assuming the 90 days horizon Eventide Healthcare is expected to generate 11.22 times less return on investment than Gmo Emerging. In addition to that, Eventide Healthcare is 4.06 times more volatile than Gmo Emerging Country. It trades about 0.0 of its total potential returns per unit of risk. Gmo Emerging Country is currently generating about 0.13 per unit of volatility. If you would invest 1,557 in Gmo Emerging Country on October 24, 2024 and sell it today you would earn a total of 434.00 from holding Gmo Emerging Country or generate 27.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Eventide Healthcare Life vs. Gmo Emerging Country
Performance |
Timeline |
Eventide Healthcare Life |
Gmo Emerging Country |
Eventide Healthcare and Gmo Emerging Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eventide Healthcare and Gmo Emerging
The main advantage of trading using opposite Eventide Healthcare and Gmo Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eventide Healthcare position performs unexpectedly, Gmo Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gmo Emerging will offset losses from the drop in Gmo Emerging's long position.Eventide Healthcare vs. T Rowe Price | Eventide Healthcare vs. Rbc Small Cap | Eventide Healthcare vs. Sp Smallcap 600 | Eventide Healthcare vs. Ab Small Cap |
Gmo Emerging vs. First Trust Specialty | Gmo Emerging vs. Blackrock Financial Institutions | Gmo Emerging vs. Angel Oak Financial | Gmo Emerging vs. T Rowe Price |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |